Past Fujirebio Diagnostics, Inc. News & Events
Press Releases 2009
December 10, 2009
Fujirebio Diagnostics Named Life Sciences Company of the Year
Eastern Technology Council Honors Malvern-based Company at Gala Awards Ceremony.
May 4, 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays
to Improve Cancer Detection and Management
BD (Becton, Dickinson and Company; NYSE: BDX) and Fujirebio Diagnostics, Inc., announced today the signing of a worldwide development and supply agreement for oncology diagnostic assays.
January 27, 2009
Fujirebio Diagnostics and Abbott Agree to Develop New Ovarian Cancer Test for Abbott's ARCHITECT® Analyzers
Fujirebio Diagnostics, Inc. and Abbott have signed a license agreement to develop a new ovarian cancer test for use on Abbott's automated ARCHITECT® diagnostic analyzers. Under the agreement, Fujirebio Diagnostics will develop and manufacture for Abbott the HE4 biomarker, a simple blood test that may help in the risk stratification of women at high risk for ovarian cancer, a difficult disease to detect in its early stage.
January 26, 2009
Pivotal Data Published for First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
A pivotal clinical trial published in the January 2009 issue of the journal Gynecologic Oncology demonstrated the utility of combining Fujirebio Diagnostics' HE4 and the CA125 test as an aid in estimating the risk of epithelial ovarian cancer in premenopausal or postmenopausal women presenting with pelvic mass. The HE4 test, which is under review by the U.S. Food and Drug Administration (FDA), was reported to successfully stratify patients into high- and low-risk groups when combined with CA125.
Events 2009
May 8-14, 2009
25th International Papillomavirus Conference, Malmo, Sweden
Download the scientific poster "Selection of Monoclonal Antibodies Detecting E7 in solution and fixed cells". Information contained is for research purposes only and not for diagnostic use.
http://www.hpv2009.org/
May 13-15, 2009
Swedish Clinical Chemistry Lab Mtg., Sweden
http://www.ltkalmar.se/lttemplates/SubjectPage____7914.aspx
May 26-28, 2009
FDAB Distributor Meeting, Athens, Greece
July 7-8, 2009
OCNA, Washington, DC
http://www.ovariancancer.org/conference/2009/
July 19-23, 2009
American Association for Clinical Chemistry, Chicago, IL
http://www.aacc.org/EVENTS/2009AM/Pages/default.aspx
August 22, 2009
Gynecologic Cancer Foundation - Sponsoring a Survivors Course, Atlanta, GA
August 24-28, 2009
SFOG 2009, Norrköping, Sweden
http://www.sfogveckan.se/
September 10-13, 2009
8th Congress of the European Society of Gynecology, Rome, Italy
www.seg-web.org
September 26-30, 2009
ISOBM 2009, Amsterdam, The Netherlands
http://www.isobm2009.nl/
October 11-14, 2009
ESGO 2009, Belgrade, Serbia
http://www2.kenes.com/ESGO/Pages/Home.aspx
November 2009
NOCC, TBD
http://www.ovarian.org/
November 2009
MEDICA, Dusseldorf, Germany
http://www.medica.de/home_2
November 12-15, 2009
COGI 2009, Beijing, China
http://www.comtecmed.com/cogi/bangkok/